Cell Biosciences Raises $10 Million
Cell Biosciences, a Palo Alto, Calif.-based provider of nanoproteomic analysis systems to life science researchers, has raised $10 million in Series C funding. The Wellcome Trust led the round, and was joined by return backers Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada and The Vertical Group.
10 April 2009•2 mins read
